US OptionsDetailed Quotes

ALLK240816C2500

Watchlist

0.05
-0.05-50.00%

15min DelayTrading Jul 22 10:09 ET

0.05High0.05Low

Allakos Stock Discussion

Trytosaveabit

Jun 25 15:07

Update

$Allakos(ALLK.US)$ Reuters· 4 mins ago
Allakos Announces Positive Results From Its Ongoing Phase 1 Trial of Ak006 in Healthy Volunteers, With Ak006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile

Jaguar8

Jun 25 15:02

NEWS

$Allakos(ALLK.US)$
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos has announced positive results from the Phase 1 trial of AK006, a Siglec-6 monoclonal antibody being developed to treat mast cell-driven diseases. The drug demonstrated high receptor occupancy on mast cells and a favorable safety profile, with no serious adverse events. Health...

MARKET-TEST-DUMMY

Jun 21 19:50

Shorts have ammo

$Allakos(ALLK.US)$expect some sideways or downward pressure

Trytosaveabit

May 28 06:04

Update! And note date!

$Allakos(ALLK.US)$ Allakos Announces First Patient Dosed in Phase 1 Trial of Ak006 in Chronic Spontaneous Urticaria! Top-Line Phase 1 Csu Results Expected at Year End 2024

71143235

Mar 1 12:59

$Allakos(ALLK.US)$ mark my words buyout rumors or news in 2-3 months

MARKET-TEST-DUMMY

Feb 1 04:18

still think it will be heading back to price gap

$Allakos(ALLK.US)$ Allakos | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.8%)
SEC announcement
·
01/29 17:30

MARKET-TEST-DUMMY

Jan 28 21:05

interesting

$Allakos(ALLK.US)$ huge price gap, will it make it back to 2.0?

$Allakos(ALLK.US)$ Allakos Announced Topline Data From Its Phase 2 Trial For Lirentelimab In Atopic Dermatitis (ATLAS) And Phase 2B Study In Chronic Spontaneous Urticaria (MAVERICK); The Studies Did Not Meet Their Primary Endpoints

Meltyy

Jan 3 06:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

No comment yet